Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-26

Clinical Trial Update: Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma) [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluating pioglitazone for moderate-to-severe asthma in obese patients was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Vermont | Conditions: Asthma, Obesity | Phase 2 | Status: TERMINATED | Results posted: 2015-02-26